home

Sanofi signs cancer pact with Asian biotech Hummingbird

EVENTSfiercebiotech2016-04-25 09:17 Read   117

In the same week that Sanofi ($SNY) invested more heavily into its European biologics center, the French drugmaker has now agreed on a new cancer antibody pact in Asia with biotech Hummingbird Bioscience.

Aptuit announces acquisition of Exquiron Biotech AG

EVENTSexquiron2016-04-25 09:05 Read   74

LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services.

Sarepta soars after FDA questions revive advocates’ hope for Duchenne drug

Commentsfiercebiotech2016-04-25 08:58 Read   89

Friday afternoon, Sarepta’s path to a formal marketing decision from the FDA on its Duchenne muscular dystrophy drug eteplirsen took yet another bizarre twist.

FDA proposes ban on electrical stimulation devices intended to treat self-injurious or aggressive behavior

RegulatorFDA2016-04-25 08:47 Read   114

The U.S. Food and Drug Administration today announced a proposal to ban electrical stimulation devices (ESDs) used for self-injurious or aggressive behavior because they present an unreasonable and substantial risk to public health that cannot be corrected or eliminated through changes to the labeling.

Actelion Chief Says No Suitors Are Courting Drugmaker With Deals

R&Dbloomberg2016-04-22 13:09 Read   90

Actelion isn’t fending off any takeover approaches, Chief Executive Officer Jean-Paul Clozel said, days after a media report cited the drugmaker as a possible target for Sanofi or Johnson & Johnson.

Novartis splits U.S. honcho's job in two as current chief Christi Shaw steps down

R&Dfiercepharma2016-04-22 13:02 Read   127

Novartis will see a changing of the guard in the U.S. next week. Christi Shaw, who has headed up the Swiss drugmaker’s U.S. operations since April 2014, is stepping down for personal and family reasons, to be replaced by two current Novartis execs.

Novo Nordisk plans to invest more than 100 million euros in production plants in Chartres, France

R&Dnovonordisk2016-04-22 12:57 Read   90

Bagsværd, Denmark, 21 April 2016 ­- Novo Nordisk today announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France.

Biogen Reports First Quarter 2016 Revenues of $2.7 Billion

R&Dbusinesswire2016-04-22 11:33 Read   224

Total revenues of $2.7 billion, a 7% increase versus the same period in the prior year. Growth was driven by a 15% increase in worldwide TECFIDERA® revenues as well as increased revenues from ELOCTATE® and ALPROLIX®.

Petnostics Wins on "Shark Tank"

EVENTSprweb2016-04-22 11:23 Read   117

On Friday, April 15, 2016, Petnostics founder Stephen Chen appeared on ABC’s "Shark Tank" seeking $300,000 in exchange for 10% equity in his company to aid the development of additional pet health products and expand the company’s retail presence nationwide. Impressed by his pitch, and Petnostics’ patented pet health technology, Lori Greiner and Kevin O'Leary paired up to offer Stephen $300,000 for 20% equity in the company.

Insurers, Drugmakers Want to Exchange Info on Specialty Drugs

Commentsmorningconsult2016-04-22 11:18 Read   92

There is a lot of disagreement about what to do about high drug costs. But in at least one case, frequent foes, insurers and drug companies, agree.

Glaxo balks at U.K.'s $54M pay-for-delay fine

EVENTSfiercepharma2016-04-22 11:14 Read   100

GlaxoSmithKline’s U.K. offices have taken exception to a major multimillion-pound fine levied by the country’s market watchdog, saying its conduct was “objectively justified.”

New Novartis meds help relieve Gleevec generics pain

Trendfiercepharma2016-04-22 11:09 Read   98

It’s accentuate-the-positive time at Novartis. The Swiss drugmaker’s sales and earnings suffered in the first quarter, thanks to an early generic version of blockbuster leukemia drug Gleevec.